SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Acadia Pharmaceuticals Inc – ‘10-K’ for 12/31/19

On:  Wednesday, 2/26/20, at 6:31pm ET   ·   As of:  2/27/20   ·   For:  12/31/19   ·   Accession #:  1564590-20-6889   ·   File #:  0-50768

Previous ‘10-K’:  ‘10-K’ on 2/27/19 for 12/31/18   ·   Next:  ‘10-K’ on 2/25/21 for 12/31/20   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/20  Acadia Pharmaceuticals Inc        10-K       12/31/19   80:12M                                    ActiveDisclosure/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.44M 
 2: EX-4.3      Instrument Defining the Rights of Security Holders  HTML     39K 
 3: EX-21.1     Subsidiaries List                                   HTML     23K 
 4: EX-23.1     Consent of Experts or Counsel                       HTML     29K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
35: R1          Document and Entity Information                     HTML     89K 
72: R2          Consolidated Balance Sheets                         HTML    108K 
50: R3          Consolidated Balance Sheets (Parenthetical)         HTML     43K 
25: R4          Consolidated Statements of Operations               HTML     71K 
36: R5          Consolidated Statements of Comprehensive Loss       HTML     40K 
73: R6          Consolidated Statements of Cash Flows               HTML    126K 
51: R7          Consolidated Statements of Stockholders' Equity     HTML     83K 
24: R8          Organization and Business                           HTML     28K 
37: R9          Summary of Significant Accounting Policies          HTML    207K 
57: R10         Investments                                         HTML    198K 
79: R11         Fair Value Measurements                             HTML    131K 
38: R12         Balance Sheet Details                               HTML    106K 
27: R13         Stockholders' Equity                                HTML    133K 
58: R14         401(k) Plan                                         HTML     27K 
80: R15         Income Taxes                                        HTML    201K 
39: R16         Commitments and Contingencies                       HTML     43K 
28: R17         Leases                                              HTML     98K 
59: R18         Selected Quarterly Financial Data (Unaudited)       HTML    110K 
78: R19         Subsequent Event                                    HTML     27K 
44: R20         SCHEDULE II - Valuation and Qualifying Accounts     HTML     74K 
15: R21         Summary of Significant Accounting Policies          HTML    267K 
                (Policies)                                                       
60: R22         Summary of Significant Accounting Policies          HTML    154K 
                (Tables)                                                         
66: R23         Investments (Tables)                                HTML    195K 
45: R24         Fair Value Measurements (Tables)                    HTML    127K 
16: R25         Balance Sheet Details (Tables)                      HTML    111K 
61: R26         Stockholders' Equity (Tables)                       HTML    120K 
67: R27         Income Taxes (Tables)                               HTML    196K 
43: R28         Leases (Tables)                                     HTML    101K 
17: R29         Selected Quarterly Financial Data (Unaudited)       HTML    109K 
                (Tables)                                                         
31: R30         Summary of Significant Accounting Policies -        HTML     36K 
                Schedule of Reconciliation of Cash, Cash                         
                Equivalents and Restricted Cash (Detail)                         
41: R31         Summary of Significant Accounting Policies -        HTML     91K 
                Additional Information (Detail)                                  
77: R32         Summary of Significant Accounting Policies -        HTML     34K 
                Schedule of Estimated Useful Lives by Major Asset                
                Category (Detail)                                                
56: R33         Summary of Significant Accounting Policies -        HTML     37K 
                Weighted-Average Assumptions Used to Estimate Fair               
                Value of Employee Stock Options (Detail)                         
30: R34         Summary of Significant Accounting Policies -        HTML     44K 
                Weighted-Average Assumptions Used to Estimate Fair               
                Value of Employee Stock Purchase Plan Rights                     
                (Detail)                                                         
40: R35         Summary of Significant Accounting Policies -        HTML     35K 
                Summary of Stock-based Compensation Expense                      
                Included in Statements of Operations (Detail)                    
76: R36         Investments - Carrying Value and Amortized Cost of  HTML     54K 
                Company's Investments Summarized by Major Security               
                Type (Detail)                                                    
54: R37         Investments - Additional Information (Detail)       HTML     28K 
29: R38         Investments - Summary of Gross Unrealized Losses    HTML     52K 
                and Fair Value of Available-For-Sale Investments                 
                in Unrealized Loss Position (Detail)                             
42: R39         Fair Value Measurements - Fair Value Measurements   HTML     52K 
                of Cash Equivalents, Available-For-Sale Investment               
                Securities and Equity Securities (Detail)                        
20: R40         Balance Sheet Details - Schedule of Inventory       HTML     36K 
                (Detail)                                                         
47: R41         Balance Sheet Details - Property and Equipment,     HTML     43K 
                Net (Detail)                                                     
71: R42         Balance Sheet Details - Additional Information      HTML     29K 
                (Detail)                                                         
65: R43         Balance Sheet Details - Schedule of Accrued         HTML     45K 
                Liabilities (Detail)                                             
19: R44         Stockholders' Equity - Additional Information       HTML    156K 
                (Detail)                                                         
46: R45         Summary of Company's Stock Option Activity          HTML     79K 
                (Detail)                                                         
70: R46         Summary of Company's RSU Activity (Detail)          HTML     51K 
64: R47         401 (k) Plan - Additional Information (Detail)      HTML     32K 
18: R48         Income Taxes - Summary of Domestic and Foreign      HTML     32K 
                Pre-tax Loss (Detail)                                            
48: R49         Income Taxes - Additional Information (Detail)      HTML     83K 
33: R50         Income Taxes - Components of Deferred Tax Assets    HTML     58K 
                (Detail)                                                         
21: R51         Income Taxes - Reconciliation of Income Taxes to    HTML     55K 
                Amount Computed by Applying Statutory Federal                    
                Income Tax Rate to Pretax Loss (Detail)                          
52: R52         Income Taxes - Unrecognized Tax Benefits (Detail)   HTML     32K 
74: R53         Commitments and Contingencies - Additional          HTML     70K 
                Information (Detail)                                             
34: R54         Leases - Additional Information (Detail)            HTML     72K 
22: R55         Leases - Summary of Operating Lease Costs (Detail)  HTML     26K 
53: R56         Leases - Supplemental Cash Flow Information         HTML     29K 
                Related to the Company's Leases (Detail)                         
75: R57         Leases - Summary of Balance Sheet Classification    HTML     33K 
                of Lease Liabilities (Detail)                                    
32: R58         Leases - Summary of Maturities of Lease             HTML     45K 
                Liabilities (Detail)                                             
23: R59         Leases - Estimated Annual Future Minimum Payments   HTML     45K 
                under Operating Leases and Other Long-term                       
                Contractual Obligation (Detail)                                  
62: R60         Selected Quarterly Financial Data (Unaudited) -     HTML     44K 
                Selected Quarterly Financial Data (Detail)                       
69: R61         Subsequent Event - Additional Information (Detail)  HTML     39K 
49: R62         SCHEDULE II - Valuation and Qualifying Accounts     HTML     35K 
                (Detail)                                                         
63: XML         IDEA XML File -- Filing Summary                      XML    143K 
55: XML         XBRL Instance -- acad-10k_20191231_htm               XML   3.04M 
26: EXCEL       IDEA Workbook of Financial Reports                  XLSX     90K 
10: EX-101.CAL  XBRL Calculations -- acad-20191231_cal               XML    204K 
11: EX-101.DEF  XBRL Definitions -- acad-20191231_def                XML    502K 
12: EX-101.LAB  XBRL Labels -- acad-20191231_lab                     XML   1.40M 
13: EX-101.PRE  XBRL Presentations -- acad-20191231_pre              XML    985K 
 9: EX-101.SCH  XBRL Schema -- acad-20191231                         XSD    179K 
68: JSON        XBRL Instance as JSON Data -- MetaLinks              369±   604K 
14: ZIP         XBRL Zipped Folder -- 0001564590-20-006889-xbrl      Zip    369K 




        
Filing Submission 0001564590-20-006889 – SGML Text

Original SGML Text submitted by:  ActiveDisclosure/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 5:13:18.2pm ET